Pre dicting D eterminants of A trial Fibrillation or Flutter for T herapy E lucidation in Patients at Risk for Thromboembolic Events (PREDATE AF) Study

Heart Rhythm - Tập 14 - Trang 955-961 - 2017
Javed M. Nasir1,2, William Pomeroy2, Adam Marler2, Matthew Hann2, Tina Baykaner1, Ronald Jones1,2, Richard Stoll2, Katherine Hursey2, Angela Meadows2, Jennifer Walker2, Steve Kindsvater2,3
1Stanford University, Stanford, California
2Keesler Medical Center, Biloxi, Mississippi
3Baylor Heart Hospital, Plano, Texas

Tài liệu tham khảo

Mozaffarian, 2015, Heart disease and stroke statistics—2015 update: a report from the American Heart Association, Circulation, 131, e29, 10.1161/CIR.0000000000000152 Lloyd-Jones, 2004, Lifetime risk for development of atrial fibrillation, Circulation, 110, 1042, 10.1161/01.CIR.0000140263.20897.42 Marini, 2005, Contribution of atrial fibrillation to incidence and outcome of ischemic stroke: results from a population-based study, Stroke, 36, 1115, 10.1161/01.STR.0000166053.83476.4a Sanna, 2014, Cryptogenic stroke and underlying atrial fibrillation, N Engl J Med, 370, 2478, 10.1056/NEJMoa1313600 Leyden, 2013, Adelaide stroke incidence study, Stroke, 44, 1226, 10.1161/STROKEAHA.113.675140 Granger, 2011, Apixaban versus warfarin in patients with atrial fibrillation, N Engl J Med, 365, 981, 10.1056/NEJMoa1107039 Hart, 2007, Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation, Ann Intern Med, 146, 857, 10.7326/0003-4819-146-12-200706190-00007 Connolly, 2009, Dabigatran versus warfarin in patients with atrial fibrillation, N Engl J Med, 361, 1139, 10.1056/NEJMoa0905561 Patel, 2011, Rivaroxaban versus warfarin in nonvalvular atrial fibrillation, N Engl J Med, 365, 883, 10.1056/NEJMoa1009638 Kirchhof, 2016, 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS, Eur Heart J, 37, 2893, 10.1093/eurheartj/ehw210 Kernan, 2014, Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack, Stroke, 45, 2160, 10.1161/STR.0000000000000024 Svennberg, 2015, Mass screening for untreated atrial fibrillation: the STROKESTOP study, Circulation, 131, 2176, 10.1161/CIRCULATIONAHA.114.014343 Engdahl, 2013, Stepwise screening of atrial fibrillation in a 75-year-old population, Circulation, 127, 930, 10.1161/CIRCULATIONAHA.112.126656 Schnabel, 2009, Development of a risk score for atrial fibrillation (Framingham Heart Study): a community-based cohort study, Lancet, 373, 739, 10.1016/S0140-6736(09)60443-8 Chamberlain, 2011, A clinical risk score for atrial fibrillation in a biracial prospective cohort, Am J Cardiol, 107, 85, 10.1016/j.amjcard.2010.08.049 Chyou, 2015, Individual and combined risk factors for incident atrial fibrillation and incident stroke: an analysis of 3 million at-risk US patients, J Am Heart Assoc, 4, e001723, 10.1161/JAHA.114.001723 Brunner, 2014, Clinical predictors of risk for atrial fibrillation: implications for diagnosis and monitoring, Mayo Clin Proc, 89, 1498, 10.1016/j.mayocp.2014.08.016 Saliba, 2016, Usefulness of CHADS2 and CHA2DS2-VASc scores in the prediction of new-onset atrial fibrillation: a population-based study, Am J Med, 129, 843, 10.1016/j.amjmed.2016.02.029 Chao, 2013, CHADS2 score and risk of new-onset atrial fibrillation: a nationwide cohort study in Taiwan, Int J Cardiol, 168, 1360, 10.1016/j.ijcard.2012.12.011 Hindricks, 2010, Performance of a new leadless implantable cardiac monitor in detecting and quantifying atrial fibrillation: results of the XPECT trial, Circ Arrhythm Electrophysiol, 3, 141, 10.1161/CIRCEP.109.877852 Lip, 2010, Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the Euro Heart Survey on atrial fibrillation, Chest, 137, 263, 10.1378/chest.09-1584 Lowres, 2013, Screening to identify unknown atrial fibrillation: a systematic review, Thromb Haemost, 110, 213, 10.1160/TH13-02-0165 Healey, 2012, Subclinical atrial fibrillation and the risk of stroke, N Engl J Med, 366, 120, 10.1056/NEJMoa1105575 Reiffel JA. REVEAL AF: incidence of AF in high risk patients. In: ClinicalTrials.gov. Bethesda, MD: National Library of Medicine. https://clinicaltrials.gov/ct2/show/NCT01727297. Cited October 21, 2016. Accessed January 3, 2017. Healey JS, Alings M, Leong-Sit P, DeGraff J, Birnie D, Freericks M, Ha A, Verma A. Prevalence of sub-clinical atrial fibrillation using an implantable cardiac monitor in patients with cardiovascular risk factors: ASSERT II. Abstract presented at: American Heart Association’s Scientific Sessions 2016; November 15, 2016; New Orleans, LA. Lowres, 2014, Feasibility and cost-effectiveness of stroke prevention through community screening for atrial fibrillation using iPhone ECG in pharmacies: the SEARCH-AF study, Thromb Haemost, 111, 1167, 10.1160/TH14-03-0231 Cullen, 2013, Risks and benefits of anticoagulation in atrial fibrillation: insights from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry, Circ Cardiovasc Qual Outcomes, 6, 461, 10.1161/CIRCOUTCOMES.113.000127 Glotzer, 2009, The relationship between daily atrial tachyarrhythmia burden from implantable device diagnostics and stroke risk: the TRENDS study, Circ Arrhythm Electrophysiol, 2, 474, 10.1161/CIRCEP.109.849638 Boriani, 2014, Device-detected atrial fibrillation and risk for stroke: an analysis of >10,000 patients from the SOS AF project, Eur Heart J, 35, 508, 10.1093/eurheartj/eht491 Shanmugam, 2012, Detection of atrial high-rate events by continuous home monitoring: clinical significance in the heart failure–cardiac resynchronization therapy population, Europace, 14, 230, 10.1093/europace/eur293 Glotzer, 2003, Atrial high rate episodes detected by pacemaker diagnostics predict death and stroke, Circulation, 107, 1614, 10.1161/01.CIR.0000057981.70380.45 Wolf, 1991, Atrial fibrillation as an independent risk factor for stroke: the Framingham Study, Stroke, 22, 983, 10.1161/01.STR.22.8.983 Healey J, Connolly S, Alings M, Lopes R. Apixaban for the Reduction of Thrombo-Embolism in Patients With Device-Detected Sub-Clinical Atrial Fibrillation (ARTESiA). In: ClinicalTrials.gov. Bethesda, (MD: National Library of Medicine. https://clinicaltrials.gov/ct2/show/NCT01938248. Cited October 21, 2016. Accessed January 3, 2017. Kirchhof P. Non-vitamin K Antagonist Oral Anticoagulants in Patients With Atrial High Rate Episodes (NOAH). In: ClinicalTrials.gov. Bethesda, MD: National Library of Medicine. https://clinicaltrials.gov/ct2/show/NCT02618577. Cited October 21, 2016. Accessed January 3, 2017.